• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bio-Path Holdings, Inc. - Common Stock (NQ:BPTH)

0.2100 UNCHANGED
Last Price Updated: 4:00 PM EST, Feb 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.2100
Bid (Size) 0.2001 (50)
Ask (Size) 0.2142 (42)
Prev. Close 0.2100
Today's Range 0.2100 - 0.2100
52wk Range N/A - N/A
Shares Outstanding 5,768,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Life Sciences Investor Forum: Now Available for Online Viewing
June 13, 2025
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Bio-Path Holdings to Present at Life Sciences Virtual Investor Forum
June 09, 2025
From Bio-Path Holdings, Inc.
Via GlobeNewswire

Performance

More News

Read More
News headline image
Life Sciences Investor Forum Agenda Announced for June 11th-12th
June 10, 2025
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 25
June 04, 2025
Via Newsfile
Topics Intellectual Property
News headline image
Bio-Path Holdings Provides Clinical and Operational Update
June 03, 2025
From Bio-Path Holdings, Inc.
Via GlobeNewswire
News headline image
Bio-Path Holdings to Host Corporate Update Conference Call on May 29, 2025
May 22, 2025
From Bio-Path Holdings, Inc.
Via GlobeNewswire
News headline image
Bio-Path Holdings Achieves Third Pre-Clinical Milestone Confirming Potential of BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients
May 01, 2025
From Bio-Path Holdings, Inc.
Via GlobeNewswire
News headline image
Bio-Path Holdings Reports Full Year 2024 Financial Results
March 28, 2025
From Bio-Path Holdings, Inc.
Via GlobeNewswire
News headline image
Bio-Path Holdings Announces Pre-Clinical Results Signaling Increased Potential for BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients
March 18, 2025
From Bio-Path Holdings, Inc.
Via GlobeNewswire
News headline image
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
February 18, 2025
Via Chartmill
News headline image
Which stocks are moving on Tuesday? ↗
February 18, 2025
Via Chartmill
News headline image
Tuesday's session: gap up and gap down stocks ↗
February 18, 2025
Via Chartmill
News headline image
US Stocks Mixed; NY State Business Activity Rises In February ↗
February 18, 2025
Via Benzinga
News headline image
Wondering what's happening in today's pre-market session? ↗
February 18, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
February 18, 2025
Via Benzinga
News headline image
Bio-Path Holdings Expands Global Patent Portfolio
February 13, 2025
From Bio-Path Holdings, Inc.
Via GlobeNewswire
News headline image
Bio-Path Holdings Provides Key Clinical Updates
February 13, 2025
From Bio-Path Holdings, Inc.
Via GlobeNewswire
News headline image
Wondering what's happening in today's after-hours session? ↗
February 12, 2025
Via Chartmill
News headline image
Bio-Path Holdings Provides Update from Phase 1/1b Clinical Trial of BP1002 for Treatment of Refractory/Relapsed Acute Myeloid Leukemia
February 12, 2025
From Bio-Path Holdings, Inc.
Via GlobeNewswire
News headline image
Bio-Path Holdings Provides 2025 Clinical and Operational Update
January 10, 2025
From Bio-Path Holdings, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
December 19, 2024
Via Benzinga
News headline image
Nasdaq Jumps 100 Points, US Initial Jobless Claims Decline ↗
December 19, 2024
Via Benzinga
News headline image
Bio-Path Holdings Shares Were On The Rise: What's Going On? ↗
December 19, 2024
Via Benzinga
News headline image
Gold Falls Sharply, Lamb Weston Shares Plunge ↗
December 19, 2024
Via Benzinga
News headline image
US Stocks Higher, Micron Reports Downbeat Sales ↗
December 19, 2024
Via Benzinga

Frequently Asked Questions

Is Bio-Path Holdings, Inc. - Common Stock publicly traded?
Yes, Bio-Path Holdings, Inc. - Common Stock is publicly traded.
What exchange does Bio-Path Holdings, Inc. - Common Stock trade on?
Bio-Path Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Bio-Path Holdings, Inc. - Common Stock?
The ticker symbol for Bio-Path Holdings, Inc. - Common Stock is BPTH on the Nasdaq Stock Market
What is the current price of Bio-Path Holdings, Inc. - Common Stock?
The current price of Bio-Path Holdings, Inc. - Common Stock is 0.2100
When was Bio-Path Holdings, Inc. - Common Stock last traded?
The last trade of Bio-Path Holdings, Inc. - Common Stock was at 02/18/25 04:00 PM ET
What is the market capitalization of Bio-Path Holdings, Inc. - Common Stock?
The market capitalization of Bio-Path Holdings, Inc. - Common Stock is 1.21M
How many shares of Bio-Path Holdings, Inc. - Common Stock are outstanding?
Bio-Path Holdings, Inc. - Common Stock has 1M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap